Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1996-3-12
|
pubmed:databankReference | |
pubmed:abstractText |
The major control point for the hypoxic induction of the vascular endothelial growth factor (VEGF) gene is the regulation of the steady-state level of the mRNA. We previously demonstrated a discrepancy between the transcription rate and the steady-state mRNA level induced by hypoxia. This led us to examine the post-transcriptional regulation of VEGF expression. Actinomycin D experiments revealed that hypoxia increased VEGF mRNA half-life from 43 +/- 6 min to 106 +/- 9 min. Using an in vitro mRNA degradation assay, the half-life of VEGF mRNA 3'-untranslated region (UTR) transcripts were also found to be increased when incubated with hypoxic versus normoxic extracts. Both cis-regulatory elements involved in VEGF mRNA degradation under normoxic conditions and in increased stabilization under hypoxic conditions were mapped using this degradation assay. A hypoxia-induced protein(s) was found that bound to the sequences in the VEGF 3'-UTR which mediated increased stability in the degradation assay. Furthermore, genistein, a tyrosine kinase inhibitor, blocked the hypoxia-induced stabilization of VEGF 3'-UTR transcripts and inhibited hypoxia-induced protein binding to the VEGF 3'-UTR. These findings demonstrate a significant post-transcriptional component to the regulation of VEGF.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Genistein,
http://linkedlifedata.com/resource/pubmed/chemical/Isoflavones,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-9258
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
2
|
pubmed:volume |
271
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2746-53
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:8576250-Animals,
pubmed-meshheading:8576250-Base Sequence,
pubmed-meshheading:8576250-Cell Hypoxia,
pubmed-meshheading:8576250-Cell-Free System,
pubmed-meshheading:8576250-Endothelial Growth Factors,
pubmed-meshheading:8576250-Genistein,
pubmed-meshheading:8576250-Isoflavones,
pubmed-meshheading:8576250-Lymphokines,
pubmed-meshheading:8576250-Molecular Sequence Data,
pubmed-meshheading:8576250-PC12 Cells,
pubmed-meshheading:8576250-RNA, Messenger,
pubmed-meshheading:8576250-RNA Processing, Post-Transcriptional,
pubmed-meshheading:8576250-Rats,
pubmed-meshheading:8576250-Transcription, Genetic,
pubmed-meshheading:8576250-Vascular Endothelial Growth Factor A,
pubmed-meshheading:8576250-Vascular Endothelial Growth Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
Post-transcriptional regulation of vascular endothelial growth factor by hypoxia.
|
pubmed:affiliation |
Cardiology Division, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|